HealthTech Startup Directors & Officers (D&O) Insurance Cost

What rating basis does Directors & Officers (D&O) use for HealthTech Startups?

Directors & Officers (D&O) for HealthTech Startups is rated per $1M of D&O limit + revenue band — that is the unit of exposure carriers use to scale premium against operations. The base rate per unit comes from carrier-proprietary loss costs, refined by each carrier with its own experience.

Two adjustments do most of the work after the base rate: your experience modifier (which captures three years of paid claims relative to expected losses) and the schedule rating credits or debits an underwriter applies based on operational quality.

Inside the HealthTech Startups Directors & Officers (D&O) premium spread

Two HealthTech Startups can both be quoted on Directors & Officers (D&O) and end up at opposite ends of the $2,160–$16,560/year range. The shape of each profile:

Low-end profile (~$2,160/year): owner-operator or small crew, no claims in three years, clean operational documentation, single-state operation, conservative scope. Eligible for standard-market preferred tiers and bundled placements.

High-end profile (~$16,560/year): larger crew or fleet, one or more paid claims in three years, broader operating territory, more aggressive scope mix. May still be in standard market but with debit pricing, or pushed to surplus depending on the carrier appetite.

carrier-proprietary class codes that govern HealthTech Startups Directors & Officers (D&O) rating

Underwriters assign HealthTech Startups a carrier-proprietary classification before any premium calculation. The assigned class determines the base loss cost per $1M of D&O limit + revenue band and constrains which carriers will quote at all.

If the class code is wrong, every downstream number is wrong. Two operations can be similar in practice but rated under different classes — and the class difference alone can swing premium 15-30%. Always verify the code on the binder.

Information needed to quote Directors & Officers (D&O) on HealthTech Startups

The information underwriters need to quote Directors & Officers (D&O) for HealthTech Startups is consistent across carriers: who you are (legal entity, ownership, years in business), what you do (revenue split, operation types, equipment, payroll), and what your history looks like (three years of loss runs and any open claims).

Submitting the package in one batch — rather than piecemeal — produces faster, sharper quotes. Underwriters who can underwrite a complete file in a single session price more aggressively than those who have to keep returning to a file as new information trickles in.

Where HealthTech Startups Directors & Officers (D&O) accounts get placed

For HealthTech Startups, Directors & Officers (D&O) accounts are concentrated among a handful of carriers with stated emerging-industry appetite. Standard-market players include the major construction-and-trade specialists; surplus-lines markets pick up the accounts those standard carriers decline.

Coverage Axis maintains an active appetite map across 50+ carriers and routinely shops HealthTech Startups Directors & Officers (D&O) risks to the three or four carriers most likely to compete on the specific operational profile. That focused approach typically produces faster turnaround and better pricing than blanket-shopping.

How does HealthTech Startups Directors & Officers (D&O) cost compare to high-growth tech?

The Directors & Officers (D&O) rate gap between HealthTech Startups and high-growth tech reflects different loss patterns in each class. HealthTech Startups produce a cyber-and-D&O-driven loss shape, which carriers price one way; high-growth tech produce a different shape and a different price.

For HealthTech Startups specifically, the unique drivers of the loss shape produce a per-unit rate that may run higher or lower than high-growth tech depending on the carrier and the year. Over a five-year cycle, the rate differential moves but the directional ranking tends to hold.

What happens to Directors & Officers (D&O) premium after a HealthTech Startups claim?

Carriers price HealthTech Startups Directors & Officers (D&O) prospectively, but they do so by looking at prior claims as the best predictor of future loss experience. A paid claim within three years means a higher expected loss for the upcoming year, which directly increases the premium needed to support the risk.

Specific impacts: claim within 12 months = 40-60% load on next renewal; claim 12-24 months ago = 25-40% load; claim 24-36 months ago = 10-25% load; claim more than 36 months ago = no direct experience-mod impact, though the carrier may still note it.